SI1954264T1 - Postopek priprave intermediatov epoksibutanola - Google Patents

Postopek priprave intermediatov epoksibutanola

Info

Publication number
SI1954264T1
SI1954264T1 SI200630502T SI200630502T SI1954264T1 SI 1954264 T1 SI1954264 T1 SI 1954264T1 SI 200630502 T SI200630502 T SI 200630502T SI 200630502 T SI200630502 T SI 200630502T SI 1954264 T1 SI1954264 T1 SI 1954264T1
Authority
SI
Slovenia
Prior art keywords
formula
epoxybutanol
intermediates
procedure
preparation
Prior art date
Application number
SI200630502T
Other languages
English (en)
Slovenian (sl)
Inventor
Marc Muller
Lin Xu
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Publication of SI1954264T1 publication Critical patent/SI1954264T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/08Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
SI200630502T 2005-12-01 2006-11-29 Postopek priprave intermediatov epoksibutanola SI1954264T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05026163 2005-12-01
EP06804890A EP1954264B1 (en) 2005-12-01 2006-11-29 Process for the manufacture of epoxybutanol intermediates

Publications (1)

Publication Number Publication Date
SI1954264T1 true SI1954264T1 (sl) 2010-01-29

Family

ID=36178579

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200630502T SI1954264T1 (sl) 2005-12-01 2006-11-29 Postopek priprave intermediatov epoksibutanola

Country Status (19)

Country Link
US (2) US7816537B2 (https=)
EP (2) EP2133345A1 (https=)
JP (1) JP5329969B2 (https=)
KR (1) KR101191682B1 (https=)
CN (1) CN101321522B (https=)
AT (1) ATE444747T1 (https=)
AU (2) AU2006319657B2 (https=)
BR (1) BRPI0619120B1 (https=)
CA (2) CA2711852C (https=)
CY (1) CY1110588T1 (https=)
DE (1) DE602006009698D1 (https=)
DK (1) DK1954264T3 (https=)
ES (1) ES2333258T3 (https=)
HR (1) HRP20090675T1 (https=)
PL (1) PL1954264T3 (https=)
PT (1) PT1954264E (https=)
SI (1) SI1954264T1 (https=)
WO (1) WO2007062542A2 (https=)
ZA (1) ZA200804218B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012003126A (es) 2009-09-21 2012-06-19 Gilead Sciences Inc Procesos e intermedios para la preparacion de analogos de 1'-carbonucleosidos sustituidos.
ES2524356T3 (es) 2010-07-22 2014-12-05 Gilead Sciences, Inc. Métodos y compuestos para tratar infecciones provocadas por virus Paramyxoviridae
CA2878361C (en) 2012-08-07 2020-09-22 Basilea Pharmaceutica Ag Process for the manufacture of isavuconazole or ravuconazole
WO2015150947A1 (en) 2014-03-29 2015-10-08 Wockhardt Limited A process for the preparation of isavuconazole and its intermediates
TWI687432B (zh) 2014-10-29 2020-03-11 美商基利科學股份有限公司 絲狀病毒科病毒感染之治療
DK3785717T3 (da) 2015-09-16 2022-03-21 Gilead Sciences Inc Fremgangsmåder til behandling af coronaviridae-infektioner
CN105367528A (zh) * 2015-11-10 2016-03-02 南通诺泰生物医药技术有限公司 一种三唑类药物中间体(d)-1-(1-环烷仲胺基)-2-(2-四氢吡喃基)氧-1-丙酮类化合物及合成方法
US10682368B2 (en) 2017-03-14 2020-06-16 Gilead Sciences, Inc. Methods of treating feline coronavirus infections
CA3059777C (en) 2017-05-01 2023-02-21 Gilead Sciences, Inc. Crystalline forms of (s)-2-ethylbutyl 2-(((s)-(((2r,3s,4r,5r)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy) phosphoryl)amino)propanoate
WO2019014247A1 (en) 2017-07-11 2019-01-17 Gilead Sciences, Inc. COMPOSITIONS COMPRISING POLYMERASE RNA INHIBITOR AND CYCLODEXTRIN FOR THE TREATMENT OF VIRAL INFECTIONS
CN110997646B (zh) 2017-08-10 2023-06-20 住友化学株式会社 环氧醇化合物的制造方法
JP2023512656A (ja) 2020-01-27 2023-03-28 ギリアード サイエンシーズ, インコーポレイテッド SARS CoV-2感染を治療するための方法
KR20220153619A (ko) 2020-03-12 2022-11-18 길리애드 사이언시즈, 인코포레이티드 1'-시아노 뉴클레오사이드의 제조 방법
CA3172483A1 (en) 2020-04-06 2021-10-14 Scott Ellis Inhalation formulations of 1'-cyano substituted carbanucleoside analogs
TW202203941A (zh) 2020-05-29 2022-02-01 美商基利科學股份有限公司 瑞德西韋之治療方法
PE20230618A1 (es) 2020-06-24 2023-04-14 Gilead Sciences Inc Analogos de nucleosido de 1'-ciano y usos de los mismos
IL300453A (en) 2020-08-27 2023-04-01 Gilead Sciences Inc COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS
KR20240154647A (ko) 2022-03-02 2024-10-25 길리애드 사이언시즈, 인코포레이티드 바이러스성 감염 치료를 위한 화합물 및 방법
US12357577B1 (en) 2024-02-02 2025-07-15 Gilead Sciences, Inc. Pharmaceutical formulations and uses thereof
CN115536643A (zh) * 2022-12-05 2022-12-30 南京桦冠生物技术有限公司 一种艾沙康唑类药物关键中间体的制备方法
CN119264078B (zh) * 2024-12-09 2025-08-01 浙江世佳科技股份有限公司 一种(5s,6r)-5,6-环氧-2-十七碳炔-1-醇的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3452213B2 (ja) * 1994-07-05 2003-09-29 エーザイ株式会社 抗真菌剤及びその製造方法
AU2931399A (en) * 1998-03-06 1999-09-20 F. Hoffmann-La Roche Ag 3-(4-(4-cyanophenyl)thiazol-2-y))-1-(1h-1,2,4-triazol-1-yl) -butan-2-ol derivatives having antifungal activity
US6133485A (en) * 1998-04-15 2000-10-17 Synphar Laboratories, Inc. Asymmetric synthesis of 2-(2,4-difluorophenyl)-1-heterocycl-1-yl butan-2,3-diols
US6391903B1 (en) * 1999-09-09 2002-05-21 Sankyo Company, Limited Triazole derivatives having antifungal activity
US6884892B2 (en) 2002-06-20 2005-04-26 Sumitomo Chemical Company, Limited Production methods of epoxytriazole derivative and intermediate therefor
JP4627413B2 (ja) * 2003-05-06 2011-02-09 三井化学株式会社 1−アゾール−2−フェニル−2、3−プロパンジオール誘導体の製造法

Also Published As

Publication number Publication date
AU2010203301B2 (en) 2012-06-21
WO2007062542A2 (en) 2007-06-07
KR20080075014A (ko) 2008-08-13
CY1110588T1 (el) 2015-04-29
AU2010203301A1 (en) 2010-08-12
ES2333258T3 (es) 2010-02-18
PL1954264T3 (pl) 2010-02-26
HRP20090675T1 (hr) 2010-01-31
CA2629092C (en) 2012-01-03
BRPI0619120A2 (pt) 2011-09-13
CA2711852A1 (en) 2007-06-07
DE602006009698D1 (de) 2009-11-19
JP2009517413A (ja) 2009-04-30
CN101321522B (zh) 2012-05-30
AU2006319657B2 (en) 2010-08-12
EP1954264B1 (en) 2009-10-07
JP5329969B2 (ja) 2013-10-30
WO2007062542A3 (en) 2007-11-01
ATE444747T1 (de) 2009-10-15
US20110021794A1 (en) 2011-01-27
BRPI0619120B1 (pt) 2023-10-10
DK1954264T3 (da) 2010-01-11
CA2629092A1 (en) 2007-06-07
CA2711852C (en) 2011-10-04
CN101321522A (zh) 2008-12-10
US8076494B2 (en) 2011-12-13
EP2133345A1 (en) 2009-12-16
US7816537B2 (en) 2010-10-19
EP1954264A2 (en) 2008-08-13
ZA200804218B (en) 2009-01-28
AU2006319657A1 (en) 2007-06-07
KR101191682B1 (ko) 2012-10-16
US20090299073A1 (en) 2009-12-03
PT1954264E (pt) 2009-12-23

Similar Documents

Publication Publication Date Title
ZA200804218B (en) Process for the manufacture of epoxybutanol intermediates
DK1613304T3 (da) DPP-IV-inhibitorer
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
TW200510381A (en) Novel 2-pyridinecarboxamide derivatives
ECSP099091A (es) Profarmaco de compuesto de cinamida
PT2192109E (pt) Derivado de -aminoácido bicíclico
EA017861B9 (ru) Способ получения 4-оксохинолинового соединения
CY1112402T1 (el) Ενισχυτες υποδοχεων γλουταμικου
SE0202838D0 (sv) Chemical compounds
TW200624421A (en) Method for preparing n-phenylpyrazole-1-carboxamides
ATE503746T1 (de) Neue imidazolidinderivate
DK1961734T3 (da) Aminforbindelse og anvendelse deraf til medicinske formål
DE60233664D1 (de) Verfahren zur herstellung von pyridinverbindungen
ATE498600T1 (de) Inden derivate als pharmazeutika
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
NZ614088A (en) Process for preparing pyridinamines and novel polymorphs thereof
UA96149C2 (en) Method for producing 4-oxoquinoline compound
DK2161260T3 (da) Semisyntesefremgangsmåde til fremstilling af 10-deacetyl-n-debenzoysl-paclitaxel
IL183805A0 (en) Process for preparing substituted thiophenesulfonyl isocyanates
EP2045258A4 (en) 3y-ETHYNYLCYTIDINDERIVAT
ATE365704T1 (de) 1-acetoxy-3-(substituiertes phenyl) propen- verbindungen verwendbar als zwischenmaterial 1
SE0402734D0 (sv) Antimiicrobial compounds
NO20053997D0 (no) Oligosaccharidderivat
CY1107067T1 (el) Αλατα δικαρφοξυλικου οξεως της βεναζεπριλης και παρασκευη της βεναζεπριλης μεσω αυτων
TH77089A (th) กระบวนการเคมี